Axsome Therapeutics, Inc. (AXSM)
164.84
-1.54
(-0.93%)
USD |
NASDAQ |
Mar 03, 14:08
Axsome Therapeutics Shareholders Equity (Quarterly) : 88.30M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 647.80M |
| Gilead Sciences, Inc. | 22.70B |
| Vanda Pharmaceuticals, Inc. | 327.19M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Amicus Therapeutics, Inc. | 274.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 689.80M |
| Total Liabilities (Quarterly) | 601.51M |
| Debt to Equity Ratio | 2.470 |
| Current Ratio | 1.555 |
| Net Debt Paydown Yield | -0.06% |